Praxis Precision Medicines, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PRAX research report →
Companywww.praxismedicines.com
Praxis Precision Medicines, Inc. , a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of major depressive disorder and perimenopausal depression; and PRAX-944, a selective small molecule inhibitor of T-type calcium channels, which is in Phase IIa clinical trial for the treatment of essential tremor.
- CEO
- Marcio Silva De'Souza
- IPO
- 2020
- Employees
- 116
- HQ
- Boston, MA, US
Price Chart
Valuation
- Market Cap
- $7.10B
- P/E
- -29.69
- P/S
- 0.00
- P/B
- 6.88
- EV/EBITDA
- -18.59
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -43.02%
- ROIC
- -25.32%
Growth & Income
- Revenue
- $0 · -100.00%
- Net Income
- $-303,268,000 · -65.88%
- EPS
- $-13.48 · -32.03%
- Op Income
- $-326,198,000
- FCF YoY
- -89.08%
Performance & Tape
- 52W High
- $358.76
- 52W Low
- $35.21
- 50D MA
- $319.87
- 200D MA
- $219.43
- Beta
- 2.78
- Avg Volume
- 406.47K
Get TickerSpark's AI analysis on PRAX
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 14, 26 | Mastrocola Lauren | other | 127 |
| May 14, 26 | Nemiroff Alex | other | 78 |
| May 14, 26 | Kelly Timothy Edwin | other | 121 |
| May 14, 26 | Sniecinski Megan | other | 89 |
| May 14, 26 | Souza Marcio | other | 126 |
| Feb 6, 26 | Arbuckle Stuart A | other | 478 |
| Feb 6, 26 | Arbuckle Stuart A | other | 688 |
| Feb 6, 26 | Arbuckle Stuart A | other | 224 |
| Feb 6, 26 | KINDLER JEFFREY B | other | 478 |
| Feb 6, 26 | KINDLER JEFFREY B | other | 688 |
Our PRAX Coverage
We haven't published any research on PRAX yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate PRAX Report →